|
End-of-day quote
Shenzhen S.E.
29/10/2026
|
5-day change | 1st Jan Change | ||
| 8.920 CNY | -1.65% |
|
-3.04% | -26.58% |
| 20/08 | Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 22/05 | Zhuhai Rundu Pharmaceutical Wins China Approval for Pain Relief Drug | MT |
| Market Cap | 298.72Cr 45Cr 40Cr 37Cr 34Cr 63Cr 4.27TCr 64Cr 441.9Cr 176.29Cr 2.23TCr 168.22Cr 164.64Cr 7.08TCr | P/E 2024 |
79.5x | P/E 2025 | -63.9x |
|---|---|---|---|---|---|
| Enterprise Value | 326.33Cr 49Cr 44Cr 40Cr 37Cr 68Cr 4.66TCr 70Cr 482.74Cr 192.59Cr 2.44TCr 183.77Cr 179.86Cr 7.73TCr | EV / Sales 2024 |
2.95x | EV / Sales 2025 | 3.69x |
| Free-Float |
42.98% | Yield 2024 |
1.57% | Yield 2025 | - |
| 1 day | -1.65% | ||
| 1 week | -3.04% | ||
| Current month | -19.13% | ||
| 1 month | -16.64% | ||
| 3 months | -14.80% | ||
| 6 months | -32.83% | ||
| Current year | -26.58% |
| 1 week | 8.92 |  | 9.65 |
| 1 month | 8.61 | | 12.51 |
| Current year | 8.61 | | 18.96 |
| 1 year | 8.61 | | 18.96 |
| 3 years | 6.81 | | 19.56 |
| 5 years | 6.81 | | 22.25 |
| 10 years | 6.81 | | 22.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Liu
CEO | Chief Executive Officer | 50 | 21/10/2018 |
Shen Hua Shi
DFI | Director of Finance/CFO | 63 | 16/04/2011 |
Chun Yan You
PRN | Corporate Officer/Principal | 50 | 18/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Bo Wang
BRD | Director/Board Member | 64 | 14/03/2023 |
Xin Min Chen
CHM | Chairman | 60 | 21/10/2018 |
Zhi Jun Hua
CHM | Chairman | 57 | 16/04/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.65% | -3.04% | -30.91% | -31.54% | 46Cr | |
| +6.63% | +5.13% | +68.86% | +145.20% | 1,14800Cr | |
| +1.53% | +2.84% | +47.48% | +89.01% | 65TCr | |
| +1.68% | +1.96% | +29.16% | +109.31% | 51TCr | |
| +0.73% | +2.45% | +54.26% | +68.96% | 38TCr | |
| +3.83% | -0.62% | +69.01% | +42.32% | 35TCr | |
| +2.38% | +2.65% | +34.31% | +57.95% | 29TCr | |
| +2.26% | +0.55% | +3.92% | +28.92% | 26TCr | |
| +1.97% | +3.01% | +57.91% | +76.14% | 24TCr | |
| +4.03% | +5.36% | +39.76% | +116.14% | 20TCr | |
| Average | +1.94% | +1.93% | +37.38% | +70.24% | 40.38TCr | |
| Weighted average by Cap. | +2.25% | +2.89% | +50.21% | +95.95% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 118.24Cr 18Cr 16Cr 15Cr 13Cr 25Cr 1.69TCr 25Cr 174.91Cr 70Cr 884.19Cr 67Cr 65Cr 2.8TCr | 117.64Cr 18Cr 16Cr 15Cr 13Cr 25Cr 1.68TCr 25Cr 174.02Cr 69Cr 879.7Cr 66Cr 65Cr 2.79TCr |
| Net income | 3.99Cr 59.85L 53.6L 49.45L 44.75L 83.68L 57Cr 85.03L 5.9Cr 2.35Cr 30Cr 2.25Cr 2.2Cr 94Cr | -6.35Cr -95.24L -85.31L -78.7L -71.22L -1.33Cr -91Cr -1.35Cr -9.39Cr -3.75Cr -47Cr -3.57Cr -3.5Cr -150.34Cr |
| Net Debt | 29Cr 4.41Cr 3.95Cr 3.64Cr 3.3Cr 6.17Cr 420.04Cr 6.27Cr 43Cr 17Cr 219.83Cr 17Cr 16Cr 696.26Cr | 28Cr 4.14Cr 3.71Cr 3.42Cr 3.1Cr 5.79Cr 394.52Cr 5.89Cr 41Cr 16Cr 206.47Cr 16Cr 15Cr 653.95Cr |
Employees
1,655
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/26/29 | CN¥8.920 | -1.65% | 54,57,651 |
| 28/26/28 | CN¥9.070 | +1.11% | 65,53,203 |
| 27/26/27 | CN¥8.970 | -3.76% | 77,32,300 |
| 26/26/26 | CN¥9.320 | +1.86% | 98,05,000 |
| 23/26/23 | CN¥9.150 | -0.54% | 1,33,04,600 |
- Stock Market
- Stocks
- 002923 Stock
Select your edition
All financial news and data tailored to specific country editions
